Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ELZONRIS®safely and effectively. See full prescribing information for ELZONRIS. ELZONRIS (tagraxofusp-erzs) injection, for intravenous use Initial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
ELZONRIS is indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older.
- generic_name
- tagraxofusp
- product_names
- tagraxofusp
- ndc
- 72187-0401, 72187-0401-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en